Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is clinical radiosensitivity a complex genetically controlled event?

Andrea Riccardo Filippi1, Pierfrancesco Franco, Umberto Ricardi

  • 1Dipartimento di Discipline Medico-Chirurgiche, Sezione di Radioterapia, Università di Torino, Italy. andrea.filippi@unito.it

Tumori
|May 27, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Axillary management in patients with cN + breast cancer undergoing neoadjuvant chemotherapy: pattern of practice in Italy.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2026
Same author

Radiotherapy as an antihemorrhagic approach in gastric cancer: the RANTIGA study.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2026
Same author

Sequential chemo-durvalumab, reduced-dose RT, and consolidation durvalumab for unresectable stage III NSCLC unfit for PACIFIC regimen (DEDALUS trial).

JNCI cancer spectrum·2026
Same author

Conventionally Fractionated Radiotherapy (CFRT) Versus Stereotactic Body Radiotherapy (SBRT) for Locally Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis of Comparative Studies.

Cancers·2026
Same author

Radiotherapy for more efficacious novel anticancer drugs: a position paper from the European Society for Radiotherapy and Oncology (ESTRO) focus group on novel systemic therapies and radiotherapy.

The Lancet. Oncology·2026
Same author

Different Pattern of Treatment Failure After Chemoradiation Between p16+ and p16- Patients Affected by Oropharyngeal Carcinoma.

Head & neck·2026

Genetic factors influence cellular radiation response and clinical radiosensitivity. Identifying specific gene variants, like Single Nucleotide Polymorphisms, can help predict radiation effects and personalize radiotherapy.

Area of Science:

  • Radiobiology
  • Molecular Biology
  • Genetics

Background:

  • Basic radiobiological studies are revealing molecular mechanisms of cellular radiation response.
  • Clinical radiosensitivity is a complex, genetically controlled trait.
  • Genes involved in radiation-induced pathways, such as DNA repair, may influence radiotherapy outcomes.

Purpose of the Study:

  • To explore the genetic basis of radiosensitivity.
  • To identify candidate genes and genetic variants influencing normal tissue and tumor response to radiotherapy.
  • To lay the groundwork for predictive testing and personalized radiation therapy.

Main Methods:

  • Analysis of preliminary data on genetic control of radiosensitivity.
  • Identification of specific gene variants, including Single Nucleotide Polymorphisms (SNPs).

Related Experiment Videos

  • Consideration of complex interactions between genetic determinants.

    • Main Results:

    • Preliminary evidence supports genetic control of clinical radiosensitivity.
    • Specific Single Nucleotide Polymorphisms (SNPs) are associated with varying normal tissue radiation effects.
    • The allelic architecture of radiosensitivity is complex and may involve gene interactions.

    Conclusions:

    • Genes involved in DNA repair and other radiation pathways are potential modulators of radiotherapy response.
    • Genetic variants, particularly SNPs, are linked to individual radiosensitivity and radiation effects.
    • Future research should focus on large patient cohorts and novel gene identification for personalized radiotherapy strategies.